By Stewart Eisenhart, Emergo Group US drug and medical device market regulators are proposing changes to voluntary and mandatory post-market reporting forms used by consumers and healthcare providers for adverse events related to medical products.
The post US FDA proposes changes to MedWatch program for healthcare products appeared first on MassDevice.
from MassDevice http://ift.tt/1KcTv4y
Cap comentari:
Publica un comentari a l'entrada